4-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)-2-hydroxypropyl)piperidin-4-yl)-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View 4-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)-2-hydroxypropyl)piperidin-4-yl)-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
	4-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)-2-hydroxypropyl)piperidin-4-yl)-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Cathepsin S Protein (Entity type)	IC50
	4-(1-(3-(3-(4-bromophenyl)-5-(methylsulfonyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl)-2-hydroxypropyl)piperidin-4-yl)-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	HLA class II histocompatibility antigen gamma chain Protein (Entity type)	IC50